Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development

H. Hegen, A. Millonig, A. Bertolotto, M. Comabella, G. Giovanonni, M. Guger, M. Hoelzl, M. Khalil, J. Killestein, R. Lindberg, S. Malucchi, M. Mehling, X. Montalban, C.H. Polman, D. Rudzki, F. Schautzer, F. Sellebjerg, P.S. Sorensen, F. Deisenhammer

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)577-587
JournalMultiple Sclerosis
Volume20
Issue number5
DOIs
Publication statusPublished - 2014

Cite this

Hegen, H., Millonig, A., Bertolotto, A., Comabella, M., Giovanonni, G., Guger, M., Hoelzl, M., Khalil, M., Killestein, J., Lindberg, R., Malucchi, S., Mehling, M., Montalban, X., Polman, C. H., Rudzki, D., Schautzer, F., Sellebjerg, F., Sorensen, P. S., & Deisenhammer, F. (2014). Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development. Multiple Sclerosis, 20(5), 577-587. https://doi.org/10.1177/1352458513503597